Find information on thousands of medical conditions and prescription drugs.

Exemestane

Exemestane (Trade name: AromasinĀ®) is an oral steroidal aromatase inhibitor used in the treatment of hormonally-responsive breast cancer.

Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Exemestant selectively targets and irreversibly binds to the aromatase enzyme, thereby inhibiting the production of estrogen.

Home
Diseases
Medicines
A
B
C
D
E
E-Base
Ecstasy (drug)
Edecrin
Edrophonium
Edrophonium chloride
Efavirenz
Effexor
Eflornithine
Elavil
Eldepryl
Elidel
Eligard
Elitek
Elixomin
Elixophyllin
Ellagic acid
Elmiron
Eloxatin
Elspar
Emtriva
Emylcamate
Enalapril
Enalaprilat
Enalaprilat
Endep
Enflurane
Enoxaparin sodium
Entacapone
Enulose
Epi-pen
Epinephrine
Epirubicin
Epitol
Epivir
Epogen
Eprosartan
Ergocalciferol
Ergoloid Mesylates
Ergotamine
Eryc
Eryped
Erythromycin
Esgic
Eskalith
Esmolol
Estazolam
Estazolam
Estrace
Estraderm
Estradiol
Estradiol
Estradiol valerate
Estring
Estrogel
Estrone
Estrostep
Ethacridine
Ethambutol
Ethchlorvynol
Ethosuximide
Ethotoin
Etiracetam
Etodolac
Etopophos
Etoposide
Etorphine
Evista
Exelon
Exemestane
Hexal Australia
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Aromatase Inhibitors (Milestones in Drug Therapy) (Milestones in Drug Therapy) $155.48 Exemestane after tamoxifen improves disease-free survival; postmenopausal women with breast cancer.(Women's Health) : An article from: Family Practice News $5.95
Exemestane beats Tamoxifen for advanced breast cancer.(Women's Health) : An article from: Internal Medicine News $5.95

Postmenopausal women with breast CA: exemestane after tamoxifen increases survival
Switching to exemestane therapy after 2-3 years of tamoxifen treatment improves disease-free survival in postmenopausal women with breast cancer, according ...
Aromasin approved as adjuvant
Aromasin (exemestane tablets) is approved as an adjuvant treatment for post-menopausal women with estrogen receptor-positive breast cancer who have received ...
Tamoxifen alone discouraged as adjuvant Tx
HOLLYWOOD, FLA. -- An aromatase inhibitor, either alone or after tamoxifen therapy, is better than tamoxifen alone for the long-term prevention of breast ...
Tamoxifen-aromatase inhibitor combo improves Ca outcomes
SAN ANTONIO -- Switching postmenopausal breast cancer patients to an aromatase inhibitor following 2-3 years of adjuvant tamoxifen results in markedly ...
ASCO: aromatase inhibitor can replace tamoxifen
Postmenopausal women with hormone receptor-positive breast cancer can take an aromatase inhibitor instead of tamoxifen as adjuvant therapy, the American ...
Off-label use: aromatase inhibitors show promise in fertility Tx
LAS VEGAS -- Aromatase inhibitors may be the answer for women in whom clomiphene fails to induce ovulation, Dr. Robert F. Casper said at the Fifth World ...
Face to face with mental health services
To get a broader feel for the experiences of mental health service users, Mental Health Nursing put out an appeal for individuals to respond to three questions about their experiences and expectation
Why get a second pathology opinion for breast cancer: an interview
Of all the tests given to a woman newly diagnosed with breast cancer, one is crucial in determining her treatment plan. It measures the tumor's "hormone ...

Home Contact Resources Exchange Links ebay